Profil
John W.
Dorbin served as Counsel at CTS Corp.
from 2005 to 2012.
He then worked as Vice President & General Counsel at Supreme Industries, Inc. from 2012 to 2018.
In 2020, he joined Arcimoto, Inc. as Secretary & General Counsel, a position he held until 2023.
Currently, he is serving as Secretary & General Counsel at DMK Pharmaceuticals Corp.
Mr. Dorbin holds a graduate degree from the University of Notre Dame and an undergraduate degree from Purdue University.
Ehemalige bekannte Positionen von John Dorbin
| Unternehmen | Position | Ende |
|---|---|---|
| DMK PHARMACEUTICALS CORPORATION | General Counsel | 27.06.2024 |
| ARCIMOTO, INC. | General Counsel | 19.10.2023 |
| SUPREME INDUSTRIES, INC. | General Counsel | 01.08.2018 |
| CTS CORPORATION | Corporate Officer/Principal | 01.02.2012 |
Ausbildung von John Dorbin
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
CTS Corp.
CTS Corp. Electronic Production EquipmentElectronic Technology Designs, manufactures and sells sensors, connectivity components and actuators to the transportation, industrial and medical markets | Electronic Technology |
Supreme Industries, Inc.
Supreme Industries, Inc. Motor VehiclesConsumer Durables Designs and manufactures industrial trucks | Consumer Durables |
University of Notre Dame
University of Notre Dame Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Arcimoto, Inc.
Arcimoto, Inc. Motor VehiclesConsumer Durables Manufactures electric vehicles, bolts and provides fleet rental services | Consumer Durables |
Purdue University
Purdue University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
DMK Pharmaceuticals Corp.
DMK Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for treatment of opioid overdose and substance-use disorders | Health Technology |
















